SBIR PHASE I- TOPIC 410 - CANCER CLINICAL TRIALS RECRUITMENT AND RETENTION TOOLS FOR PARTICIPANT ENGAGEMENT.
SBIR PHASE I- TOPIC 410 - CANCER CLINICAL TRIALS RECRUITMENT AND RETENTION TOOLS FOR PARTICIPANT ENGAGEMENT.
SBIR 第一阶段 - 主题 410 - 癌症临床试验招募和保留参与者参与的工具。
批准号：
10269299
负责人：
HOWARD ISENSTEIN
金额：
$40.0万
依托单位：
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-09-16 至 2021-06-15
关键词：
Cancer PatientClinical ResearchClinical TrialsComputer softwareConsensusDataEducationFeedbackGoalsHealthInstitutional Review BoardsInterviewLawsLettersNeeds AssessmentOncologistOncologyParticipantPatient RecruitmentsPatientsPhasePrivacyRegulationResearchResearch Project GrantsReview LiteratureSecuritySiteSmall Business Innovation Research GrantSurveysSystemTechnologyTestingbasecancer clinical trialprospectiveprototyperecruittoolusability
中文摘要
翻译
该研究项目旨在创建有针对性的内容和软件OncoEngage，以增加临床试验中肿瘤患者的招募。总体目标是帮助临床研究协调员和其他人吸引潜在的参与者加入试验。第一阶段的重点是创建有针对性的内容，以吸引和招募临床试验参与者，并调整客户关系管理软件，使研究人员能够有效地执行参与活动，以招募潜在的参与者。
英文摘要
This research project seeks to create targeted content and software, OncoEngage, to increase recruitment of oncology patients in clinical trials. The overall goal is to aid clinical research coordinators and others to engage prospective participants to join trials. The Phase I is focused on creating targeted content to engage and recruit participants into clinical trials and adapting customer relationship management software to enable research staff to efficiently and effectively perform engagement activities to recruit prospective participants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
